Compound information
- Natural Products
- NACP126185
- Molecular Formula
- C18H24O3
- Molecular Weight
- 288.172544628 g/mol
- Structure
-
- IUPAC Name
- 4-(3,7-dimethylocta-2,6-dienoxy)-3-methoxy-benzaldehyde
- InChI
- InChI=1S/C18H24O3/c1-14(2)6-5-7-15(3)10-11-21-17-9-8-16(13-19)12-18(17)20-4/h6,8-10,12-13H,5,7,11H2,1-4H3
- InChI Key
- SRLAFDUAEAXGBA-UHFFFAOYSA-N
- SMILES
- O=CC1=CC=C(OCC=C(C)CCC=C(C)C)C(OC)=C1
- CAS
- 64961-07-5
- SuperClass
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- SubClass
- Monoterpenoids
- Source
- CNP0245785
Warheads
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 35.53 Å2 | LogP | 5.491 |
LogS | -4.878 | LogD | 3.829 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.988 | Pgp substrate | 0.057 |
HIA | 0.972 | F20 % | 0.95 |
F30 % | 0.321 | Caco-2 | -4.38 |
MDCK | -4.563 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.864 | PPB | 98.264 |
VD | 1.789 | Fu | 1.343 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 1.0 | CYP1A2 substrate | 0.383 |
CYP2A6 substrate | 0.447 | CYP2B6 substrate | 0.586 |
CYP2C19 inhibitor | 0.549 | CYP2C19 substrate | 0.746 |
CYP2C8 substrate | 0.645 | CYP2C9 inhibitor | 0.383 |
CYP2C9 substrate | 0.689 | CYP2D6 inhibitor | 0.002 |
CYP2D6 substrate | 0.43 | CYP2E1 substrate | 0.249 |
CYP3A4 inhibitor | 0.141 | CYP3A4 substrate | 0.443 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.773 | CL | 13.42 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.955 | Hepatotoxicity | 0.12 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.003 |
FDAMDD | 0.131 | Skin Sensitization | 0.998 |
Carcinogenicity | 0.11 | Eye Corrosion | 0.004 |
Eye Irritation | 0.847 | Respiratory Toxicity | 0.816 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.845 | IGC50 | 3.697 |
LC50FM | 5.615 | LC50DM | 6.372 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.225 | NR-AR-LBD | 0.225 |
NR-AhR | 0.026 | NR-Aromatase | 0.088 |
NR-ER | 0.201 | NR-ER-LBD | 0.371 |
NR-PPAR-gamma | 0.199 | SR-ARE | 0.29 |
SR-ATAD5 | 0.377 | SR-HSE | 0.134 |
SR-MMP | 0.77 | SR-p53 | 0.168 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.